Navigation Links
Aethlon Medical (AEMD) Note: Since September 30th, 2011 / Thank You Shareholders
Date:2/5/2013

e or achievements of Aethlon Medical, Inc. to be materially different from any future results, performance, or achievements expressed or implied by the forward-looking statements. Such potential risks and uncertainties include, without limitation, that the FDA will not approve the initiation of the Company's clinical programs or provide market clearance of the company's products, future human studies whether revenue or non-revenue generating from either compassionate use or non-compassionate use of the Aethlon ADAPT™ system or the Aethlon Hemopurifier® as an adjunct therapy to improve patient responsiveness to established cancer or hepatitis C therapies or sepsis therapies or as a standalone cancer or hepatitis C therapy or standalone sepsis therapy, the Company's ability to raise capital when needed, the Company's ability to complete the development of its planned products, the Company's ability to manufacture its products either internally or through outside companies and provide its services, the impact of government regulations, patent protection on the Company's proprietary technology, product liability exposure, uncertainty of market acceptance, competition, technological change, and other risk factors. In such instances, actual results could differ materially as a result of a variety of factors, including the risks associated with the effect of changing economic conditions and other risk factors detailed in the Company's Securities and Exchange Commission filings. The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise.

Contacts:

James A. Joyce
Chairman and CEO
858.459.7800 x301
jj@aethlonmedical.com

Jim Frakes
Chief Financial Officer
858.459.7800 x300

SOURCE Aethlon Medical, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Aethlon Medical Discloses CEO Interview
2. Aethlon Medical (AEMD) Note: Extracorporeal Methods to Reduce Inflammation in Sepsis
3. Aethlon Medical To Present Today At The 15th International Conference On Dialysis
4. Aethlon Medical Announces the Appointment of Laszlo Radvanyi, Ph.D. to its Scientific Advisory Board
5. Aethlon Medical (AEMD) Note: A Medical Device Strategy to Address Metastatic Melanoma
6. Aethlon Medical Receives Intent to Issue Notice on European Patent to Remove Hepatitis C Virus (HCV), Human Immunodeficiency Virus (HIV), and Other Viral Pathogens From Blood
7. Aethlon Medical Discloses MD Anderson Cancer Center Presentation
8. Aethlon Medical Discusses Therapeutic Device Strategies to Address Cancer, Hepatitis-C and Sepsis with the Wall Street Transcript
9. Aethlon Medical Announces Renewal of DARPA Dialysis-Like Therapeutics Contract
10. Aethlon Medical Announces the Appointment of Thomas V. Wornham and Philip A. Ward to its Board of Directors
11. Aethlon Medical (AEMD) Note: Cancer Treatment Publication Authored by Aethlon Medical Researchers Now Available
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/1/2015)... MENLO PARK, Calif. , June 1, 2015 /PRNewswire/ ... medical device company that is providing innovative evidence-based solutions ... it has commenced an underwritten public offering of its ... by Nevro and 2,459,175 shares to be sold by ... grant the underwriters a 30-day option to purchase up ...
(Date:6/1/2015)... MENLO PARK, Calif. , June 1, ... (OTCQX: DMPI) ("DelMar" and the "Company"), a biopharmaceutical ... therapies in new orphan drug indications, today announced ... trial of  VAL-083  (dianhydrogalactitol) in patients with refractory ... form of human brain cancer. Results ...
(Date:6/1/2015)... CEFALY Technology , the creators of ... authorized for use prior to the onset of migraine ... trial showing that the Cefaly device returns normal metabolic ... patients, namely the orbitofrontal cortex and rostral cingulate. ... an imaging test of the brain, used a radioactive substance called a ...
Breaking Medicine Technology:Nevro Announces Proposed Public Offering of Common Stock 2Nevro Announces Proposed Public Offering of Common Stock 3DelMar Pharmaceuticals Presents Updated Phase I/II Clinical Data on VAL-083 in Refractory Glioblastoma Multiforme (GBM) at ASCO 2DelMar Pharmaceuticals Presents Updated Phase I/II Clinical Data on VAL-083 in Refractory Glioblastoma Multiforme (GBM) at ASCO 3DelMar Pharmaceuticals Presents Updated Phase I/II Clinical Data on VAL-083 in Refractory Glioblastoma Multiforme (GBM) at ASCO 4DelMar Pharmaceuticals Presents Updated Phase I/II Clinical Data on VAL-083 in Refractory Glioblastoma Multiforme (GBM) at ASCO 5DelMar Pharmaceuticals Presents Updated Phase I/II Clinical Data on VAL-083 in Refractory Glioblastoma Multiforme (GBM) at ASCO 6DelMar Pharmaceuticals Presents Updated Phase I/II Clinical Data on VAL-083 in Refractory Glioblastoma Multiforme (GBM) at ASCO 7DelMar Pharmaceuticals Presents Updated Phase I/II Clinical Data on VAL-083 in Refractory Glioblastoma Multiforme (GBM) at ASCO 8New Study Shows CEFALY Returns Normal Metabolic Activity to Brain Areas in Migraine Patients 2
... Clinical Development for the Treatment of ... Opioid Bowel Dysfunction, ... presented positive results this week from Phase,1 and preclinical studies of ... in Las Vegas, Nevada. NKTR-118 is,Nektar,s proprietary oral therapy being studied ...
... physician leading clinical trials, FREEPORT, N.Y., ... in treating facial bruising from injectable cosmetic,treatments ... known for,treating under-eye circles. Pinoxide is ... (BMTd),created by AGI Dermatics and formulated in ...
Cached Medicine Technology:Positive Results for NKTR-118 (oral PEG-naloxol) Presented at American Academy of Pain Management Meeting 2Positive Results for NKTR-118 (oral PEG-naloxol) Presented at American Academy of Pain Management Meeting 3Positive Results for NKTR-118 (oral PEG-naloxol) Presented at American Academy of Pain Management Meeting 4Positive Results for NKTR-118 (oral PEG-naloxol) Presented at American Academy of Pain Management Meeting 5Promising Results in Treating Facial Bruising From Injectables 2
(Date:6/1/2015)... The Muscular Dystrophy Association is offering an ... the sold out 2015 Bank of America Chicago ... by signing up through the organization's nationwide endurance ... , This national endurance program includes world-class training ... a supportive community of teammates, volunteers, coaches and ...
(Date:6/1/2015)... Portland, Ore. (PRWEB) June 01, 2015 ... Plans (AHIP) announced today a new, interactive Affordable ... support large employers. The course, called “Affordable Care ... care professionals with the strategic and consultative insights ... employers as they navigate the impacts of the ...
(Date:6/1/2015)... a leading web-base electronic healthcare software (EHR) is providing ... Louisiana. The entrepreneurial trio behind Sharenote, will travel to ... with the tools and resources to monitor key performance ... , Find out why Sharenote is the EHR ... 250 practices. , Four Day Schedule , ...
(Date:6/1/2015)... June 01, 2015 KC and Monica ... $88,000 of the best superfood products in ... floods in Texas. , "Monica and I are ... News in distributing Living Fuel Super Meals - SuperBerry®, ... millennial floods in Texas," KC Craichy said. "We have ...
(Date:6/1/2015)... FL (PRWEB) June 01, 2015 More than ... the summer months when school is out and they lose ... Dairy Month and America’s dairy farmers and milk companies are ... in need with The Great American Milk Drive. , ... milk provided in the school cafeteria for the bulk of ...
Breaking Medicine News(10 mins):Health News:Sold Out 2015 Bank of America Chicago Marathon and Marine Corps Marathon Entries Still Available through MDA Team Momentum 2Health News:Cambia Partners with AHIP to Offer Expert Series ACA Training Course 2Health News:Cambia Partners with AHIP to Offer Expert Series ACA Training Course 3Health News:Nearly $100,000 In Emergency Food Aid to Flood Victims in Texas Provided by Living Fuel and Natural News 2Health News:Nearly $100,000 In Emergency Food Aid to Flood Victims in Texas Provided by Living Fuel and Natural News 3Health News:Summer Nutrition Vital for Kids who Depend on Schools for Healthy Foods 2
... of Michigan scientists have found that a deficiency in a key ... type of adult brain cancer. The study, conducted in mice that ... and a way to screen for the disease early. Appearing ... in mice show for the first time that:, Glioblastoma, the ...
... A closer look at regulatory and clinical concerns with ... to an educational advisory by the International Society for ... issue of The Journal of Heart and Lung ... Thoracic transplant patients ...
... Georgia to use a new, cutting edge diagnostic ... outcomes. , , WOBURN, Mass., and VEDBAEK, Denmark, ... Medical Center in Savannah, Georgia has implemented AdvanDx,s PNA FISH(R) ... than conventional methods to help their physicians, pharmacists and nurses ...
... addresses limitations of current randomized trials , , ... Inc . highlighted recent clinical panel presentations underscoring ... for treating asthma in adults and children. The company ... to mixed results in some randomized trials of eNO-guided ...
... Cordex Pharma, Inc. (OTC Bulletin Board: CDXP) announced ... has approved the design of pivotal, Phase 2b/3 clinical ... drug for the acute treatment of patients with paroxysmal ... process. , , ATPace(TM) is a novel ...
... China, June 2 /PRNewswire-Asia/ -- China Nepstar Chain Drugstore,Ltd. ... "Company"), the largest drugstore,chain in China based on the ... Mr. Jason (Xinghua) Wu as the Chief Operating,Officer. ... overseeing,procurement, logistics, store development and store operations. He ...
Cached Medicine News:Health News:Most common brain cancer may start in neural stem cells 2Health News:Most common brain cancer may start in neural stem cells 3Health News:Most common brain cancer may start in neural stem cells 4Health News:More stringent evaluation on the use of generic medications in thoracic transplantation 2Health News:Memorial University Medical Center (MUMC) Implements PNA FISH(R) Tests to Help Provide Best Care for Patients with Bloodstream Infections 2Health News:Memorial University Medical Center (MUMC) Implements PNA FISH(R) Tests to Help Provide Best Care for Patients with Bloodstream Infections 3Health News:Clinical Utility of Exhaled Nitric Oxide Highlighted By American Thoracic Society Panel 2Health News:Cordex Receives Special Protocol Assessment Approval from FDA for ATPace(TM) 2Health News:Cordex Receives Special Protocol Assessment Approval from FDA for ATPace(TM) 3Health News:Cordex Receives Special Protocol Assessment Approval from FDA for ATPace(TM) 4Health News:China Nepstar Chain Drugstore Appoints Chief Operating Officer 2Health News:China Nepstar Chain Drugstore Appoints Chief Operating Officer 3
... CTi Wrist OTS is an off-the-shelf wrist orthotic designed ... of 3 pre-set ranges-of-motion (20°,35° and 50°). , ... sprains with TFCC tear-triangular fibrocartilage complex , ... nonunion , Partial tendon rupture , ...
... The CTi Wrist Static is a solid, one-piece ... in a stable, neutral position. , ,Indications: , ... TFCC tear-triangular fibrocartilage complex , Coles fracture ... , Partial tendon rupture , ORIF ...
The Universal Wrist/Forearm Splint is ideal for post-surgical immobilization, post-fracture casting, wrist sprains and strains....
... wrist orthotic designed to limit the extension of the ... ,Indications: , Wrist reconstruction , Wrist ... Coles fracture - distal radius , Scaphoid ... ORIF - Open reduction and internal fixation for ...
Medicine Products: